WEST PHARMACEUTICAL SERVICES, INC. Proceeds from Long-Term Debt Issued
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Proceeds from Long-Term Debt Issued of $164.70 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-10-24
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $129.70M.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for the quarter ending 2023-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for the quarter ending 2014-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for the quarter ending 2014-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for fiscal 2015 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for fiscal 2013 was $43.20M, a 74.30% decline from fiscal 2012.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from issuance of long-term debt for fiscal 2012 was $168.10M, a 83950.00% increase from fiscal 2011.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $129.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $164.70M 10-Q · filed 2024-10-24 | |||
| 2024-06-30 | $35.00M 10-Q · filed 2024-07-25 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | ||||
| 2015-12-31 | $0.00 10-K · filed 2016-02-26 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | $0.00 10-K · filed 2016-02-26 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $0.00 derived: sum of 2 quarters · filed 2014-11-03 | $0.00 10-Q · filed 2014-11-03 | -$100.00K derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | -$100.00K derived: sum of 3 quarters · filed 2016-02-26 | -$100.00K derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | -$100.00K derived: sum of 2 quarters · filed 2016-02-26 | -$100.00K derived: sum of 3 quarters · filed 2016-02-26 | -$100.00K derived: sum of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$100.00K derived: sum of 2 quarters · filed 2016-02-26 | -$100.00K derived: sum of 3 quarters · filed 2016-02-26 | $43.20M 10-K · filed 2016-02-26 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $0.00 derived: sum of 2 quarters · filed 2014-11-03 | $43.30M 10-Q · filed 2014-11-03 | $43.40M derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $43.30M 10-Q · filed 2014-08-01 | $43.40M derived: sum of 3 quarters · filed 2015-02-25 | $211.40M derived: sum of 4 quarters · filed 2015-02-25 | |
| 2013-03-31 | $43.30M 10-Q · filed 2014-05-08 | $43.40M derived: sum of 2 quarters · filed 2015-02-25 | $211.40M derived: sum of 3 quarters · filed 2015-02-25 | $211.40M derived: sum of 4 quarters · filed 2015-02-25 | |
| 2012-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $168.10M derived: sum of 2 quarters · filed 2015-02-25 | $168.10M derived: sum of 3 quarters · filed 2015-02-25 | $168.10M 10-K · filed 2015-02-25 | $168.00M 10-K · filed 2013-02-27 |
| 2012-09-30 | $168.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $168.00M derived: sum of 2 quarters · filed 2013-11-04 | $168.00M 10-Q · filed 2013-11-04 | $168.20M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | $200.00K derived: sum of 3 quarters · filed 2014-02-27 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-06 | $200.00K derived: sum of 2 quarters · filed 2014-02-27 | |||
| 2011-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $200.00K 10-K · filed 2014-02-27 | $0.00 10-K · filed 2013-02-27 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-05 | ||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |